Nuocytes are cytokine-secreting cells of innate type 2 immunity that have critical roles in immune responses to parasitic worm infection 1 . These cells have many characteristics that suggest they may share a developmental lineage with natural helper cells 2 and innate helper cells 3, 4 . For example, nuocytes express the lymphoid growth factor receptor interleukin 7 receptor α-chain (IL-7Rα), and natural and innate helper cells both require signaling via the common γ-chain for development. Attempts to differentiate nuocytes into other lymphoid or myeloid cells have been unsuccessful 1 and, similar to natural helper cells, nuocytes cannot be induced to become T cells after culture on OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1 cells) 2 .
Nuocytes represent a rare cell population in naive mice, but their numbers increase considerably in response to IL-25, IL-33 or helminth infection 1, 5 and in asthma models 6, 7 , in which these cells constitute a major early source of IL-5 and IL-13, cytokines of type 2 immunity. In addition to their roles in protective immunity to helminths, these cytokines initiate many of the responses characteristic of allergic asthma 8, 9 . Lymphoid cells of innate type 2 immunity have also been characterized in humans, with more of these cells in samples from people with chronic rhinosinusitis 10 . Thus, nuocytes represent an important cell in diseases mediated by type 2 immune responses, such as asthma and allergy. Although nuocytes share many characteristics with lymphoid cells, they do not express lineage markers (lineage negative (Lin − )), their development is not impaired in B cell-and T celldeficient, recombination-activating gene 2-deficient mice 1 and their origin is unknown at present. However, they do share phenotypic and functional similarities with T helper type 2 cells, expressing inducible costimulator (ICOS), the receptor IL-17BR and the receptor for IL-33 (also known as T1 or ST2) and responding to IL-25 and IL-33 by abundant secretion of IL-5 and IL- 13 (refs. 1,11-13) .
The innate lymphoid cell (ILC) family has expanded from the prototypic members of natural killer (NK) cells and lymphoid tissue-inducer (LTi) cells to encompass the closely related ILC22 and ILC17 cells [14] [15] [16] [17] [18] . Notably, LTi, ILC17 and ILC22 cells are all dependent on expression of the transcription factor RORγt 14, 19, 20 . However, RORγt is not required for the development of nuocytes or natural helper cells 1, 2 .
Although all cell types of the immune response are phenotypically and functionally distinct from each another, they are all derived from a common ancestral hematopoietic stem cell (HSC) 21, 22 . Downstream of HSCs, the developing progenitors show increasing lineage restriction. Common lymphoid progenitors (CLPs) are Lin − IL-7Rα + Flt3 + cells committed toward the T cell, B cell, NK cell and plasmacytoid dendritic cell lymphoid lineages. In contrast, common myeloid progenitors (Lin − IL-7Rα − Sca-1 − c-Kit + ) give rise to cells of the granulocyte, macrophage and erythroid lineages. Signaling by IL-7 through IL-7Rα is crucial for lymphopoiesis in vivo 23 but not for NK cell development 24 , and IL-7Rα is a principal molecular marker of lymphoid progenitors but not of myeloid lineages 25 . Here we examine the lineage specificity of nuocytes and the signals that induce their development. We found that nuocytes developed from CLPs, requiring IL-33, IL-7 and Notch signaling. We also demonstrated that the transcription factor RORα (encoded by Rora) was critical for the development of nuocytes and their role in parasitic worm clearance.
A r t i c l e s

RESULTS
Nuocytes in the bone marrow are distinct from CLPs
The presence of the leukocyte common antigen CD45 on nuocytes suggests they may have a hematopoietic origin 1 . Except for T cells, all leukocytes develop in the fetal liver or bone marrow and are released into the circulation as either mature or immature cells. As many of the markers found on nuocytes, such as c-Kit and Sca-1, mirror those on hematopoietic progenitor cells, we determined whether nuocytes were distinct from these progenitors. We used multicolor flow cytometry to assess the expression of various surface markers for nuocytes 1 (IL-17BR, ICOS or ST2) and CLPs 26 (Flt3) in the bone marrow ( Fig. 1a and Supplementary Fig. 1a ). All three nuocyte markers were restricted to the Lin − IL-7Rα + Flt3 − non-CLP population ( Fig. 1a ) and this nuocyte subset represented >60% of cells in the Lin − IL-7Rα + Flt3 − population.
Another hallmark of nuocytes is the secretion of IL-5 and IL-13 in response to IL-33. To confirm that the Lin − IL-7Rα + Flt3 − population showed enrichment for functional nuocytes, we purified both Lin − IL-7Rα + Flt3 + (CLPs) and Lin − IL-7Rα + Flt3 − cells from the bone marrow of naive mice and cultured them in the presence of IL-7 with or without IL-33. Only the Lin − IL-7Rα + Flt3 − cells produced IL-4, IL-5 and IL-13 in response to IL-7 and IL-33 ( Fig. 1b) . Thus, nuocytes were present in bone marrow (~0.015% of total non-red blood cells) and were distinct from CLPs.
Nuocyte development requires IL-7 signaling
The IL-7 signaling pathway is critical for early T cell and B cell development in vivo 24 , and fate mapping with Il7r reporter mice has shown that all T cells, but very few myeloid cells, are derived from an IL-7R + lymphoid progenitor 25 . We assessed the functional importance of IL-7 signaling on nuocyte development in vivo with mice deficient in IL-7Rα (Il7r −/− ; called 'Il7ra −/− ' here). Il7ra −/− mice had significantly fewer nuocytes (CD4 − CD19 − ICOS + IL-17BR + ) in the bone marrow than did wild-type control mice ( Fig. 1c) . Furthermore, the administration of IL-25 did not induce nuocytes in the peritoneal cavity of Il7ra −/− mice, in contrast to the induction of nuocytes in similarly treated wild-type control mice ( Fig. 1d) . Thus, as with other lymphoid lineages, IL-7 signaling is required for nuocyte development.
Nuocyte development requires Notch signaling in vitro
The OP9 stromal cell line supports early hematopoiesis 27 , and OP9 cells that express the Notch ligand Delta-like 1 (OP9-DL1 cells) support T cell development 28 . We cultured purified bone marrow-derived CLPs together with OP9 or OP9-DL1 cells in the presence of factors that promote the development of T cells (IL-7 and Flt3L) or nuocytes (IL-7 and IL-33). As expected, CLPs cultured in the absence of Notch ligands in the presence of IL-7 and Flt3L developed into B cells ( Fig. 2a) , whereas CLPs grown on OP9-DL1 cells with IL-7 and Flt3L differentiated into T cells over a 20-to 26-day period ( Fig. 2a and Supplementary Fig. 2a ) by progressing through CD44 + CD25 + and CD44 lo CD25 − stages and expressing the αβ T cell antigen receptor (TCRαβ; Supplementary  Fig. 2b,c) . CLPs cultured on OP9-DL1 cells with IL-7 and IL-33 did not give rise to T cells up to day 20 (at IL-7 concentrations of over 2.5 ng/ml; Supplementary Fig. 3) , and most cells maintained expression of CD44 and CD25 (Supplementary Fig. 2c ). These cells also upregulated the nuocyte markers ICOS and ST2 and were Lin − ( Fig. 2a and Supplementary Fig. 2a ), with more than 70% of the surviving cells expressing both ICOS and ST2 by day 20. Notably, CLPs failed to differentiate into nuocytes on OP9 stromal cells even in the presence of IL-7 and IL-33 and instead developed into B cells ( Fig. 2a) . Transfer of cells between OP9-DL1 and OP9 cultures suggested that developing nuocytes required the presence of a Notch signal for the first 3-6 d of culture, after which time they were committed to nuocyte development ( Supplementary Fig. 4 ). Thus, Notch signaling, which is critical for T cell development, was also essential for the differentiation of nuocytes from CLPs in vitro. Efforts to establish a role for Notch signaling in vivo proved inconclusive ( Supplementary Fig. 5 ).
Analysis of the secretion of type 2 cytokines in supernatants from the OP9-DL1 cultures demonstrated that CLPs cultured with IL-7 and IL-33 had higher expression of IL-4, IL-5 and IL-13 than did CLPs cultured with IL-7 and Flt3L ( Fig. 2b) . Intracellular cytokine staining confirmed that ST2 + ICOS + cells produced both IL-13 and IL-5 ( Supplementary Fig. 2a ). Thus, Notch signaling was critical for nuocyte development.
Clonal expansion of nuocytes from CLPs
We sought to determine the clonal frequency of CLPs with nuocyte progenitor potential relative to that of common myeloid progenitors (CMPs) and HSCs. We sorted CLPs, CMPs or HSCs at a density of one or five cells per well in wells containing OP9-DL1, IL-7 and IL-33. After 18 d of culture, ~25% of the CLP clones that began as one cell (21 of 84 clones) had expanded in the presence of IL-7 and IL-33 ( Fig. 3a) . We detected no clonal expansion from one-cell or five-cell cultures of CMPs or HSCs (0 of 60 wells each; Fig. 3a ). The CLP-derived clones were negative for the T cell, B cell and NK cell markers CD4, CD8, CD3, CD19 and NKp46 (data not shown) but did express the nuocyte markers ICOS and ST2 (Fig. 3b) . Intracellular cytokine staining of the CLP-derived cells confirmed that they were nuocytes that produced both IL-5 and IL-13 ( Fig. 3c) . Therefore, nuocytes could be clonally expanded in vitro from CLPs but could not be derived directly from HSCs in vitro under conditions of signaling by Notch, IL-7 and IL-33.
In vivo CLP reconstitution gives rise to nuocytes
To determine the cell fate of CLPs under more physiological conditions, we assessed whether CLPs gave rise to nuocytes in vivo in adoptive-transfer experiments. We mixed purified Lin − IL-7Rα + Flt3 + CLPs 26 (Supplementary Fig. 1b ), Lin − IL-7Rα − Sca-1 + c-Kit + HSCs or Lin − IL-7Rα − Sca-1 − c-Kit + CMPs (Supplementary Fig. 1c ) from CD45.1 + B6/SJL mice with CD45.2 + C57BL/6 total bone marrow cells. We then adoptively transferred the mixtures into lethally irradiated CD45.2 + C57BL/6 mice. At 3 weeks after cell transfer, HSCs had reconstituted the recipient mice, giving rise to B cells, T cells and CD11b + myeloid cells in the blood (Supplementary Fig. 6a ), whereas CLPs gave rise mostly (>97%) to cells of the lymphoid lineage: B cells and T cells ( Supplementary Fig. 6b ). We detected no granulocytes from the donor CLPs (data not shown). Although CMPs readily differentiated into myeloid cells in vitro ( Supplementary Fig. 7) , they failed to give rise to any myeloid cells in vivo at the time point analyzed (data not shown). Furthermore, we were unable to detect successful CMP reconstitution even when we analyzed mice between 2 and 4 weeks after implantation (data not shown). The failure of donor CMPs to reconstitute the recipient mice was most probably due to the poor self-renewing capacity of CMPs in vivo 29 .
At 6 weeks after the initial cell transfer, we gave the recipient mice IL-25 for 4 d to induce nuocyte population expansion and then assessed the presence of CD45.1 + donor-derived nuocytes in the mesenteric lymph nodes of mice reconstituted with HSCs or CLPs. Donor-derived CD45.1 + nuocytes were present in mice that received HSCs (Fig. 4a) , which confirmed their hematopoietic origin. More notably, we also detected nuocytes in mice given transplantation of CLPs (Fig. 4a) , which confirmed the lymphoid heritage of nuocytes in vivo. We observed no donor-derived nuocytes in mice given transplantation of CMPs and treated with IL-25 (data not shown). CD45.1 + nuocytes were also present in the peritoneal lavage fluid of mice given transplantation of HSCs and CLPs. To confirm the efficiency of the adoptive transfer, we assessed other cell lineages in the peritoneum. Donor HSCs reconstituted both myeloid and lymphoid lineages, as we found CD45. npg A r t i c l e s peritoneum (Fig. 4b) .
In contrast, donor CLPs gave rise only to lymphoid cells, such as B cells, T cells and nuocytes ( Fig. 4b) , but not to CD45.1 + eosinophils, in the peritoneum of mice that received CLPs (Fig. 4b) . Thus, CLPs represented the in vivo precursor of nuocytes.
Thymocytes at double-negative stage 1 or 2 retain nuocyte potential Notch signaling serves an essential role in the development of T cells by restricting the myeloid and B cell potential of developing T cells 30, 31 . The differentiation of progenitor cells into mature T cells involves several cellular stages defined by cell surface expression of markers, including CD44 and CD25, on CD4 − CD8 − double-negative (DN) early T cell subsets, with cells at DN stage 1 (DN1), DN2, DN3 and DN4 becoming more T cell restricted as they progress from DN1 to DN4 (ref. 31) . We sought to determine whether T cell progenitors in the thymus also retained the plasticity to become nuocytes. We purified Lin − DN1 (CD44 + CD25 − ), Lin − DN2 (CD44 + CD25 + ) and Lin − DN3 (CD44 − CD25 + ) thymic subsets and cultured them as either single cells or as 100 cells on OP9 or OP9-DL1 monolayers in the presence of IL-7 and IL-33. Culture on OP9-DL1 cells plus IL-7 and IL-33 resulted in the population expansion of ~10% of the single-cell DN1 colonies and 100% of the 100-cell DN1 colonies (Fig. 5a) . For DN2 cell cultures, single-cell colonies did not expand but ~50% of the 100-cell colonies did expand (Fig. 5a) , whereas ~20% of the single-cell DN3 cultures expanded and ~50% of the 100-cell colonies DN3 cultures expanded (Fig. 5a) . Analysis of the cell surface expression of ICOS and ST2 showed that all colonies that started as DN1 cells and 11-100% of the DN2 clones (depending on the experiment) developed a Lin − ST2 + ICOS + phenotype similar to that of nuocytes, but the DN3 clones did not ( Fig. 5a and Supplementary Fig. 8a) . The variation in the proportion of DN2 clones that developed into nuocytes was probably due to contamination with DN3 cells, because after more restricted gating to avoid DN3 cells, 100% of the DN2 clones developed into nuocytes (data not shown). In populations derived from DN1 or DN2 cells, nuocytes represented ~96% of cells and expressed IL-13, as measured by intracellular cytokine staining ( Supplementary  Fig. 8b) . The small number of remaining cells were NK cells or T cells (a proportion of which were IL-13 + ; data not shown). DN3 cells all developed into T cells when cultured on OP9-DL1 monolayers in the presence of IL-7 and IL-33 ( Fig. 5a and Supplementary  Fig. 8c ), which indicated that cells at the DN3 stage had extinguished their nuocyte potential. OP9 monolayers lacking Notch ligand provided extremely poor support for cell survival or growth for DN cells cultured with IL-7 and IL-33 (data not shown). Thus, thymocytes at the DN1 and DN2 stages of development retained the ability to develop into nuocytes. However, the experiments reported above did not address whether the same cell retained the potential to give rise to both T cells and nuocytes. To address this, we sorted single DN1, DN2 or DN3 cells into individual wells containing OP9-DL1 monolayers in the presence of only IL-7 and expanded the clones for 10-12 d to generate sufficient cells for subsequent analysis. We then divided the surviving clones into wells containing OP9-DL1 cells and IL-7 alone, IL-7 plus IL-33, or IL-7 plus Flt3L. Even in the absence of Flt3L, IL-7 induced T cell development from DN1 and DN2 starting cells at a high proportion (70-85%), similar to results obtained for cells cultured with IL-7 plus Flt3L (data not shown). However, the addition of IL-33, even after prolonged culture with IL-7, resulted in nuocyte development of all surviving cultures (up to 80% by day 38 ; Fig. 5b,c) , which indicated that individual cells in the DN1 and DN2 populations retained the plasticity to give rise to T cells or nuocyte progeny. In contrast, DN3 clones gave rise to T cells even in the presence of IL-33 ( Fig. 5b) .
Despite the finding that DN1 and DN2 precursors retained nuocyte development potential, Foxn1 nu/nu (nude) mice, which are athymic because of developmental failure of the thymic epithelium, showed normal nuocyte development (Fig. 5d ). This indicated that signals for nuocyte development were available at extrathymic sites. Notch ligands are expressed by bone marrow stromal cells 30 , and we detected IL-33 expression in naive CD45 + bone marrow cells in reporter mice in which sequence encoding the yellow fluorescent protein derivative citrine has been knocked into Il33 ( Supplementary  Fig. 9 ). This suggested that bone marrow may represent an important niche for nuocyte development. RORa is essential for efficient nuocyte development To further characterize the developmental requirements of nuocytes from wild-type mice, we used quantitative PCR to confirm the expression of a subset of genes encoding transcription factors and signaling molecules previously identified by gene-expression profiling of nuocytes 1 . Among those genes, Notch1 had high expression, as did Notch2, Id2, Tcf7 and Bcl11b (Fig. 6a) . Notably, although the expression of Rorc (encoding RORγt) was relatively low, Rora expression was higher (Fig. 6a) . The transcription factor RORα is related to RORγt but has only a minor role in the development of the T H 17 subset of helper T cells 32 . Given the reported role of RORγt in the development of LTi cells and ILCs, we investigated whether RORα has a role in nuocyte development. For this we used staggerer (Rora sg/sg ) mice, which have a spontaneous deletion in Rora that prevents translation of the ligand-binding homology domain and gives rise to a phenotype similar to RORα deficiency 33 . The injection of IL-25 to expand nuocyte populations in vivo failed to induce nuocytes in Rora sg/sg mice, in contrast to the nuocyte population expansion in their wild-type littermates (Fig. 6b) . The proportion of CD4 + T cells was not altered by the absence of RORα (Fig. 6b) . Nuocytes are critical for intestinal goblet-cell hyperplasia and eosinophilia after IL-25 treatment 1 . Histological examination demonstrated that Rora sg/sg mice failed to develop goblet-cell hyperplasia ( Fig. 6c,d) or eosinophilia (Fig. 6e) 
npg
A r t i c l e s Rora sg/sg mice have profound neurobiological defects that result in a failure to thrive and small size, although Rora sg/sg mice have no intrinsic defects in T cell or B cell development 34 . Therefore, we generated bone marrow chimeras by transferring bone marrow from CD45.2 + Rora sg/sg mice or their wild-type littermates into irradiated CD45.1 + recipient mice to circumvent the potential confounding effects of the neural abnormalities. At 6-8 weeks after bone marrow transfer, we gave the reconstituted mice IL-25 to induce nuocyte population expansion. Despite the similar hematological repopulation in both groups of recipients (Fig. 6f) , mice that received Rora sg/sg bone marrow had a considerable deficit in IL-25-driven nuocyte production relative to that of recipients that received wild-type bone marrow (Fig. 6g) . We observed no differences in the other lymphocyte populations after treatment with IL-25 (data not shown). Thus, the presence of RORα was critical for normal nuocyte development.
Intrinsic RORa expression is required for nuocyte development
To determine whether RORα acts in a nuocyte-intrinsic manner, we purified CLPs from the bone marrow of Rora sg/sg mice or their wildtype littermates and assessed their ability to develop into nuocytes when plated onto OP9-DL1 stromal cells in the presence of IL-7 and IL-33 or of IL-7 plus Flt3L. Both Rora sg/sg and wild-type CLPs gave rise to T cells (Fig. 7a) . However, in contrast to wild-type CLPs, Rora sg/sg CLPs failed to develop into nuocytes after culture with IL-7 and IL-33 ( Fig. 7a) , although we detected a small proportion of nuocytes in Rora sg/sg CLP cultures by day 28 (Supplementary Fig. 10) .
To confirm the intrinsic role of RORα in nuocyte development in vivo, we generated mixed-bone marrow chimeras. We irradiated CD45.1 + mice and reconstituted them with a 1:1 mixture of total bone marrow from CD45.2 + Rora sg/sg mice and CD45.1 + wild-type mice. At 6-8 weeks after bone marrow transfer, we administered IL-25 intraperitoneally and looked for nuocytes. Despite the similar hematological repopulation potential of the two types of bone marrow (Fig. 7b,c) , Rora sg/sg bone marrow did not give rise to nuocytes, whereas control wild-type bone marrow did (Fig. 7b,c) . We confirmed those results by intracellular IL-13 staining (Fig. 7d) . T cell development was not altered appreciably by the absence of RORα (Fig. 7c) . Therefore, the role of RORα in nuocyte development was cell autonomous.
Rora sg/sg mice have impaired immunity to parasitic helminths The adoptive transfer of nuocytes into recipients that are normally unable to expel the parasitic helminth Nippostrongylus brasiliensis results in the rapid expulsion of worms from the intestine 1 . As Rora sg/sg mice have deficient numbers of nuocytes, we investigated their ability to expel parasitic worms. We infected Rora sg/sg mice and their wild-type littermates with N. brasiliensis and assessed worm burdens after 6 d. Analysis at later time points was hindered by the poor health of the Rora sg/sg mice. However, even at the 6-day time point, mice with RORα deficiency had severely impaired worm clearance relative to that of wild-type mice (Fig. 8a) . Nuocyte population expansion was not induced in Rora sg/sg mice by the presence of the parasite (Fig. 8b) .
To confirm that the impaired worm clearance of Rora sg/sg mice was due to defects in the hematopoietic system, we generated bone marrow chimeras by reconstituting irradiated wild-type CD45.1 + mice with CD45.2 + Rora sg/sg or wild-type total bone marrow. At 6 weeks after reconstitution, we infected the recipient mice with N. brasiliensis and analyzed them 5-11 d later. Although mice reconstituted with wildtype bone marrow rapidly expelled their worm burden, those reconstituted with Rora sg/sg bone marrow had impaired worm expulsion and failed to induce nuocyte population expansion (Fig. 8c,d) . However, except for a single mouse reconstituted with Rora sg/sg bone marrow, both groups had expelled the worms by day 11 (data not shown). The two groups had a similar frequency of T cells (Fig. 8e) , which indicated that although worm expulsion was delayed in the recipients of Rora sg/sg bone marrow, the ability to mount an adaptive immune response remained intact. Thus, in the absence of RORα, nuocytes failed to develop and parasitic worm clearance was impaired.
DISCUSSION
Despite the fact that nuocytes share surface markers with lymphoid progenitor cells, here we have demonstrated that nuocytes are a distinct cell type that arise from cells restricted to the lymphoid lineage. By in vitro OP9-DL1 assays, we have shown that CLPs differentiated into nuocytes in the presence of IL-7, IL-33 and Notch signaling. We further demonstrated the lymphoid ancestry of nuocytes by in vivo CLP-reconstitution assays. Furthermore, we found that individual DN1 and DN2 T cell progenitors retained the plasticity to develop into nuocyte-like cells in vitro after culture with IL-7 and IL-33 and activation of Notch. However, continued nuocyte development in Foxn1 nu/nu mice indicated that the thymic microenvironment was not essential for nuocyte development. We found no evidence of nuocytes arising from CMPs. The RORα member of the ROR transcription factor family was essential for efficient nuocyte development.
Il7r expression studies designed to map the fate of cells that have previously expressed Il7r have demonstrated that lymphoid-restricted progenitors are the main route to T cells 25 . Our in vivo and in vitro assays demonstrated that IL-7 signaling was also essential for nuocyte development from CLPs when in combination with IL-33. Our findings also confirmed the lymphoid origin of these cells. We found that the in vitro development of nuocytes from CLPs depended on Notch signaling. The latter has many roles in hematopoiesis and the immune system. Deletion of Notch1 or of the Notch signaling components Rbpjκ or Jagged1 in embryos has demonstrated that Notch signaling is essential for definitive hematopoiesis, although it does not seem to be required for the long-term population expansion of HSCs in adult bone marrow 35, 36 . Notch signaling serves an essential role during thymic commitment to the T cell lineage and maturation 35 . Inducible ablation of Notch1 or Rbpjκ results in a block in T cell development and a concurrent outgrowth of B cells in the thymus 37, 38 . It is now evident that Notch1 maintains T cell potential while inhibiting many alternative cell-fate potentials, including the potential to develop into B cells, NK cells and myeloid cells 39, 40 , through its interaction with its ligand Dll4 (refs. 41,42) . Our data indicated that Notch signaling was also crucial for the development of nuocytes in vitro. Those findings suggest that nuocytes may be more closely related to T cells than to B cells or NK cells, which do not require Notch signaling for their development. Notch signaling has been linked to the differentiation of T helper type 2 cells 43, 44 , and inhibition of Notch signaling results in diminished allergic airway responses 45 . Published reports have demonstrated a critical role for Notch signaling in the development of ILC22 cells in vitro 46 . However, the physiological role of Notch in the development of those cells or nuocytes in vivo remains to be established conclusively.
RORγt is essential for the development of ILC17 and ILC22 cells from fetal liver precursors in a manner similar to that for LTi cells 47 . However, RORγt is not required for nuocyte development 1 . Our data have now demonstrated that nuocytes, in contrast, rely on RORα for their development. Although the role of RORα in neuronal cell development has long been appreciated, its importance in the immune system has surfaced only recently 32 . Subsequent to the finding that T H 17 differentiation requires RORγt, it was shown that a residual amount of T H 17 activity can be ascribed to RORα, which indicates that there may be a small amount of redundancy between RORα bioactivity and RORγt bioactivity. RORα has been associated with asthma in a genome-wide association study comparing people with diagnosed asthma and unaffected people 48 . That study also highlighted the association of asthma with IL-33 and its receptor ST2, which are required for nuocyte development 1 . The link between RORα and asthma is also supported by lung function studies of staggerer mice, which show a deficit in the production of type 2 cytokines and partial protection from airway hyper-reactivity 49 . Nuocytes are upregulated in mouse models of asthma and act as a major innate source of IL-13 (ref. 6). Thus, RORα expression in nuocytes may underlie the association of RORα with asthma in humans.
Collectively, our findings have provided new insight into the lymphoid ancestry of nuocytes and have demonstrated that nuocytes required the IL-7, IL-33, Notch and RORα signaling pathways for their development. Although the underlying molecular events that lead to the differentiation of CLPs into nuocytes are still unclear, we have now identified RORα as a critical transcription factor in nuocyte development. Our study has identified a further, previously unrecognized developmental pathway for CLPs and has indicated an additional level of complexity in lymphoid cell development, with signaling via IL-33 and IL-25 leading to the diversion of CLPs toward the nuocyte pathway for the provision of a rapid source of IL-13 and IL-5.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
